Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States. (2023). Indo-American Journal of Life Sciences and Biotechnology, 20(1), 15-46. https://iajlb.org/index.php/iajlb/article/view/210